Historical move from Abdi İbrahim: It became a partner of the Swiss for 4.2 billion liras

Abdi İbrahim, which has made a name for itself with its investments in R&D in recent years, is Abdi İbrahim, located in Switzerland, the leading country of the pharmaceutical industry, and operating in the field of respiratory and infection. =”klink”>Bought 28.5 percent of OM Pharma

Historic move from Abdi İbrahim

Shown as Turkey’s largest pharmaceutical company, Abdi İbrahim continues to reap the rewards of its R&D investments in the sector in recent years. The pharmaceutical company, which makes Turkey’s chest proud with its working conditions and world-class technological equipment, has owned 28.5 percent of OM Pharma in Switzerland for 83 years.

Announcing the sale transaction from Abdi İbrahim with the slogan of a historical move, the company said, “As Abdi İbrahim, which has been operating in the pharmaceutical industry for 108 years, we have OM Pharma, established in Switzerland, the leading country of the pharmaceutical industry, for 83 years. We are happy to share that we have acquired the pharmaceutical company together with a Swiss joint venture group!” made a statement.

Fed Chairman: Bitcoin is a Speculative Asset